Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - TOTAL ASSETS
Total Assets HALO - Halozyme Therapeutics, Inc.
1.73 B
LAST VALUE
25.27%
2 YEAR CAGR
31.53%
5 YEAR CAGR
32.77%
10 YEAR CAGR